Literature DB >> 2907486

Absence of receptor reserve at striatal dopamine receptors regulating cholinergic neuronal activity.

E Meller1, A Enz, M Goldstein.   

Abstract

N-propylnorapomorphine (NPA) dose dependently increased rat striatal ACh levels (ED50 = 18 micrograms/kg). After irreversible dopamine (DA) receptor inactivation with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ), neither the ED50 nor the slope of the dose-response curve for NPA was altered, whereas the maximal response was reduced to 56% of control. Analysis of the results yielded a linear relationship between receptor occupancy and response (i.e. no receptor reserve). In contrast, DA autoreceptors display a large receptor reserve for NPA. The results support the hypothesis that a differential receptor reserve at pre- vs. postsynaptic DA receptors in rat striatum accounts for the autoreceptor selectivity of DA agonists.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2907486     DOI: 10.1016/0014-2999(88)90413-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  12 in total

Review 1.  Pharmacology of signaling induced by dopamine D(1)-like receptor activation.

Authors:  Ashiwel S Undieh
Journal:  Pharmacol Ther       Date:  2010-06-12       Impact factor: 12.310

2.  The partial D2-like dopamine receptor agonist terguride acts as a functional antagonist in states of high and low dopaminergic tone: evidence from preweanling rats.

Authors:  Sanders A McDougall; Rita M Hernandez; Carmela M Reichel; Cristal M Farley
Journal:  Psychopharmacology (Berl)       Date:  2004-11-18       Impact factor: 4.530

3.  Kinetic properties of the in vivo accumulation of 3H-(-)-N-n-propylnorapomorphine in mouse brain.

Authors:  S B Ross; D M Jackson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-07       Impact factor: 3.000

4.  Behavioral effects of dopamine receptor inactivation in the caudate-putamen of preweanling rats: role of the D2 receptor.

Authors:  Taleen Der-Ghazarian; Crystal B Widarma; Arnold Gutierrez; Leslie R Amodeo; Joseph M Valentine; Danielle E Humphrey; Ashley E Gonzalez; Cynthia A Crawford; Sanders A McDougall
Journal:  Psychopharmacology (Berl)       Date:  2013-09-22       Impact factor: 4.530

Review 5.  Clozapine, atypical antipsychotics, and the benefits of fast-off D2 dopamine receptor antagonism.

Authors:  Georges Vauquelin; Sophie Bostoen; Patrick Vanderheyden; Philip Seeman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-02-14       Impact factor: 3.000

6.  Age-dependent effects of dopamine receptor inactivation on cocaine-induced behaviors in male rats: Evidence of dorsal striatal D2 receptor supersensitivity.

Authors:  Cynthia A Crawford; Angie Teran; Goretti I Ramirez; Caitlin G Katz; Alena Mohd-Yusof; Shannon E Eaton; Vanessa Real; Sanders A McDougall
Journal:  J Neurosci Res       Date:  2019-07-15       Impact factor: 4.164

7.  Behavioral effects of selective and nonselective dopamine agonists on young rats after irreversible antagonism of D1 and/or D2 receptors.

Authors:  S A McDougall; C A Crawford; A J Nonneman
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Dopamine receptor inactivation in the caudate-putamen differentially affects the behavior of preweanling and adult rats.

Authors:  T Der-Ghazarian; A Gutierrez; F A Varela; M S Herbert; L R Amodeo; S Charntikov; C A Crawford; S A McDougall
Journal:  Neuroscience       Date:  2012-09-19       Impact factor: 3.590

9.  Effects of irreversible dopamine receptor inactivation on locomotor activity and grooming in the 17- and 90-day-old rat.

Authors:  S A McDougall; C A Crawford; A J Nonneman
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

10.  Effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on the prolactin suppression induced by a series of full and partial dopamine D2 receptor agonists in male rats.

Authors:  A Ekman; E Eriksson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-08       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.